A Study of U3-1402 (Patritumab Deruxtecan) in Subjects With Metastatic Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Erika Hamilton, MD
SCRI Development Innovations, LLC
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- Highlands Oncology Group
Springdale, Arkansas, United States
- City of Hope
Duarte, California, United States
- Florida Cancer Specialists-South
Fort Myers, Florida, United States
- Florida Cancer Specialists-North
St. Petersburg, Florida, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Rutgers-Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
- Levine Cancer Institute
Charlotte, North Carolina, United States
- Scri Oncology Partners
Nashville, Tennessee, United States
- Tennessee Oncology
Nashville, Tennessee, United States
- Fred Hutchinson Cancer Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 3 May 2021
- Primary completion
- 9 Apr 2025
- Completion
- 9 Apr 2025
- Last update posted
- 22 May 2026
- Registered enrollment
- 121
- Registry id
- NCT04699630
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.